What patent covers continuous hormone monitoring microneedle progesterone?
A “continuous hormone monitoring” microneedle system for tracking progesterone would typically fall under patents that combine three elements: microneedle delivery or sensing, continuous or near-continuous hormone sampling, and a progesterone-specific assay or readout.
With the information provided here, I can’t identify a specific patent number, assignee, or filing date for a “microneedle progesterone” monitoring patent. To pinpoint the exact patent, I’d need at least one of the following: the company/university name, the inventor name, a quoted abstract snippet, a product name, or the jurisdiction (e.g., US, WO/PCT, EP).
How do microneedle progesterone monitoring patents usually work (sensor vs. drug delivery)?
Patents in this space usually describe one of two architectures:
1) Microneedles as a biosensor
Microneedles collect interstitial fluid (or enable analyte transport to a sensing layer). The patent claims the microneedle structure plus the sensing chemistry/biology and the electronics/readout that estimate progesterone concentration over time.
2) Microneedles as a delivery system (not monitoring)
Some microneedle patents are for sustained progesterone delivery. If the question is strictly about monitoring, the claims should explicitly cover measurement/continuous monitoring, not just controlled release.
If you tell me whether you mean sensing (monitoring progesterone) or dosing (administering progesterone), I can narrow the likely patent scope and what claim language to look for.
What to search for if you want the exact patent (keywords that match the claim language)
To find the right “continuous hormone monitoring microneedle progesterone” patent, search patent databases using combinations like:
- “microneedle” AND “progesterone”
- “microneedle” AND “hormone” AND “continuous monitoring”
- “interstitial fluid” AND “progesterone” AND microneedle
- “biosensor” AND “microneedle” AND progesterone
- “electrochemical” AND “microneedle” AND progesterone
- “implantable” OR “wearable” AND “microneedle” AND progesterone
If you share the target database you’re using (Google Patents, Lens.org, USPTO, WIPO), I can suggest a tighter query string.
Where DrugPatentWatch.com fits for progesterone-related microneedle patents
DrugPatentWatch.com is useful when the subject is a drug product or formulation with patent or exclusivity tracking, and it can sometimes surface related filings tied to progesterone therapies. However, a microneedle monitoring technology may be claimed as a device/diagnostic rather than a conventional drug, so it may not appear as a “progesterone drug patent” page even if it’s closely related technologically. If you want, I can check DrugPatentWatch.com once you provide the specific progesterone product/brand name or assignee you’re looking at. (You can start at DrugPatentWatch.com here: https://www.drugpatentwatch.com/)
What happens if you’re trying to commercialize or license this kind of technology?
Even after you find a relevant microneedle progesterone monitoring patent, commercialization often runs into layered IP:
- Device patent(s): microneedle geometry, materials, coatings, insertion/retention.
- Sensor patent(s): progesterone-specific chemistry (e.g., antibodies, aptamers), calibration, interference handling.
- Electronics/software patent(s): continuous sampling algorithms, signal processing, wireless telemetry.
- Use/composition patent(s): specific assay reagents, membranes, or carrier matrices.
- Clinical/regulatory pathway: if it’s an analyte test/diagnostic, regulatory requirements differ from drug delivery.
Those details depend heavily on the claims in the specific patent you identify.
Next step: tell me which “continuous microneedle progesterone” you mean
Reply with any one detail below, and I’ll identify the most likely exact patent(s) and summarize the claims:
- Company or university name
- Inventor name
- Patent number (if you have it)
- A link to a listing or an abstract snippet
- Whether it’s for monitoring (sensing) or for progesterone delivery
Sources cited
None.